Cancer Genetics

You have full text access to this OnlineOpen article

Frequent gene dosage alterations in stromal cells of epithelial ovarian carcinomas

  1. Hanna Tuhkanen1,2,3,
  2. Maarit Anttila1,3,
  3. Veli-Matti Kosma1,4,
  4. Seppo Heinonen3,
  5. Matti Juhola5,
  6. Seppo Helisalmi6,
  7. Vesa Kataja2,
  8. Arto Mannermaa1,4,7,†,*

Article first published online: 26 APR 2006

DOI: 10.1002/ijc.21785

Issue

International Journal of Cancer

International Journal of Cancer

Volume 119, Issue 6, pages 1345–1353, 15 September 2006

Additional Information

How to Cite

Tuhkanen, H., Anttila, M., Kosma, V.-M., Heinonen, S., Juhola, M., Helisalmi, S., Kataja, V. and Mannermaa, A. (2006), Frequent gene dosage alterations in stromal cells of epithelial ovarian carcinomas. Int. J. Cancer, 119: 1345–1353. doi: 10.1002/ijc.21785

Author Information

  1. 1

    Department of Pathology and Forensic Medicine, University of Kuopio and Kuopio University Hospital, Kuopio, Finland

  2. 2

    Department of Oncology, University of Kuopio and Kuopio University Hospital, Kuopio, Finland

  3. 3

    Department of Obstetrics and Gynecology, University of Kuopio and Kuopio University Hospital, Kuopio, Finland

  4. 4

    Department of Pathology, Center for Laboratory Medicine, University of Tampere and Tampere University Hospital, Tampere, Finland

  5. 5

    Department of Pathology, Jyväskylä Central Hospital, Jyväskylä, Finland

  6. 6

    Department of Neurology and Neurosciences, Brain Research Unit, Clinical Research Center/Mediteknia, University of Kuopio, Kuopio, Finland

  7. 7

    Department of Clinical Genetics, University of Oulu and Oulu University Hospital, Oulu, Finland

  1. †

    Fax: +358-17-162753.

*Department of Pathology and Forensic Medicine, University of Kuopio, P.O. Box 1627, FI-70211 Kuopio, Finland

Publication History

  1. Issue published online: 7 JUL 2006
  2. Article first published online: 26 APR 2006
  3. Manuscript Accepted: 29 NOV 2005
  4. Manuscript Received: 29 JUN 2005

Funded by

  • Special Government Funding of Kuopio and Tampere University Hospitals (EVO)
  • Finnish Cancer Foundation
  • Cancer Fund of North Savo
  • Finnish Medical Foundation
  • Finnish Cultural Foundation
  • University Foundation of Kuopio

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (236K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ian Campbell, Wen Qiu, Izhak Haviv, Genetic changes in tumour microenvironments, The Journal of Pathology, 2011, 223, 4
    Direct Link:
  2. 2
    Tamas A. Gonda, Andrea Varro, Timothy C. Wang, Benjamin Tycko, Molecular biology of cancer-associated fibroblasts: Can these cells be targeted in anti-cancer therapy?, Seminars in Cell & Developmental Biology, 2010, 21, 1, 2

    CrossRef

  3. 3
    Daniel L. Worthley, Andrew S. Giraud, Timothy C. Wang, Stromal Fibroblasts in Digestive Cancer, Cancer Microenvironment, 2010, 3, 1, 117

    CrossRef

  4. 4
    M Garayoa, J L Garcia, C Santamaria, A Garcia-Gomez, J F Blanco, A Pandiella, J M Hernández, F M Sanchez-Guijo, M-C del Cañizo, N C Gutiérrez, J F San Miguel, Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors, Leukemia, 2009, 23, 8, 1515

    CrossRef

  5. 5
    Qinghua Feng, Georgios Deftereos, Stephen E. Hawes, Joshua E. Stern, Julia B. Willner, Elizabeth M. Swisher, Longfu Xi, Charles Drescher, Nicole Urban, Nancy Kiviat, DNA hypermethylation, Her-2/neu overexpression and p53 mutations in ovarian carcinoma, Gynecologic Oncology, 2008, 111, 2, 320

    CrossRef

  6. 6
    Wen Qiu, Min Hu, Anita Sridhar, Ken Opeskin, Stephen Fox, Michail Shipitsin, Melanie Trivett, Ella R Thompson, Manasa Ramakrishna, Kylie L Gorringe, Kornelia Polyak, Izhak Haviv, Ian G Campbell, No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas, Nature Genetics, 2008, 40, 5, 650

    CrossRef

  7. 7
    Heli Pennanen, Outi Kuittinen, Taina Turpeenniemi-Hujanen, Plasma MMP-2-TIMP-2 complex levels measured during follow-up predict a risk of relapse in patients with malignant lymphoma, European Journal of Haematology, 2008, 80, 1
    Direct Link:
View Full Article (HTML) Get PDF (236K)